Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iridex (IRIX) Equity Average (2016 - 2025)

Historic Equity Average for Iridex (IRIX) over the last 15 years, with Q3 2025 value amounting to $5.4 million.

  • Iridex's Equity Average rose 5635.46% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 5635.46%. This contributed to the annual value of $5.8 million for FY2024, which is 5656.94% down from last year.
  • As of Q3 2025, Iridex's Equity Average stood at $5.4 million, which was up 5635.46% from $3.5 million recorded in Q2 2025.
  • Iridex's 5-year Equity Average high stood at $26.3 million for Q3 2021, and its period low was $1.5 million during Q1 2025.
  • Moreover, its 5-year median value for Equity Average was $15.6 million (2023), whereas its average is $13.9 million.
  • Within the past 5 years, the most significant YoY rise in Iridex's Equity Average was 5635.46% (2025), while the steepest drop was 8158.03% (2025).
  • Iridex's Equity Average (Quarter) stood at $26.1 million in 2021, then tumbled by 32.37% to $17.7 million in 2022, then crashed by 38.86% to $10.8 million in 2023, then plummeted by 78.13% to $2.4 million in 2024, then soared by 127.54% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $3.5 million for Q2 2025, and $1.5 million during Q1 2025.